---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-013743"
form_type: "8-K"
ticker: "NHTC"
cik: "0000912061"
company_name: "NATURAL HEALTH TRENDS CORP"
filed_at: "2026-04-29T23:59:59+00:00"
generated_at: "2026-05-15T02:37:29.744630+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NHTC Q1 2026 revenue $9.2M, down 14% YoY; net loss $154k vs prior year income

## Summary
- Revenue $9.2M, down 6% from Q4 2025 and 14% from Q1 2025.
- Net loss $154k ($0.02 diluted EPS) vs net income $122k ($0.01) in Q1 2025.
- Operating loss $474k; restructuring savings of ~$300k in the quarter.
- Active members 26,400, down from 30,180 a year ago.
- Declared $0.10/share quarterly dividend payable May 22, 2026.

## SEC filing metadata
- accession: 0001437749-26-013743
- form_type: 8-K
- ticker: NHTC
- cik: 0000912061
- company_name: NATURAL HEALTH TRENDS CORP
- filed_at: 2026-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/0001437749-26-013743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/nhtc20260306_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-013743
- JSON: https://secwatch.observer/filing/0001437749-26-013743.json
- Plain text: https://secwatch.observer/filing/0001437749-26-013743.txt

## Key facts
- Earnings Releases
  NATURAL HEALTH TRENDS CORP reported the quarter ended March 31, 2026 results: revenue $9.2 million, net income $154,000, EPS $0.02 per diluted share.
  - Period: the quarter ended March 31, 2026
  - Revenue: $9.2 million
  - Net income: $154,000
  - EPS: $0.02 per diluted share
  - Result: reported results
  source text: First Quarter 2026 Financial Highlights • Revenue of $9.2 million decreased 6% compared to $9.7 million in the fourth quarter of 2025 and declined 14% compared to $10.7 million in the first quarter of 2025. • Operating loss was $474,000 compared to $635,000 in the fourth quarter of 2025 and $345,000 in the first quarter of 2025. • Net loss was $154 ,000, or $0.02 per diluted share, compared to $588,000, or $0.05 per diluted share, in the fourth quarter of 2025 and net income of $122,000, or $0.01 per diluted share, in the first quarter of 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/912061/000143774926013743/0001437749-26-013743-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.